VIM and neoplasm: Immunohistochemistry of CRbCs showed strong cytoplasmic paranuclear positivity for vimentin in the majority (≥75%) of tumor cells (Figure 1C) in five cases and in significant areas ((≥30%) of two cases (Table 3).